Table of Contents

November 01, 2021; Volume 18,Issue 4

B

  1. Bai, Rilan

    1. Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052

  2. Bai, Xueli

    1. Multiplex imaging reveals the architecture of the tumor immune microenvironment
      Junlei Zhang, Jinyuan Song, Jianpeng Sheng, Xueli Bai and Tingbo Liang
      Cancer Biology & Medicine November 2021, 18 (4) 949-954; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0494

C

  1. Chen, Fengyang

    1. Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas
      Ping Li, Fengyang Chen, Jingbin Zheng, Yang Yang, Yuan Li, Yifei Wang and Xin Chen
      Cancer Biology & Medicine November 2021, 18 (4) 1010-1020; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0027

  2. Chen, Huijing

    1. Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022

  3. Chen, Naifei

    1. Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052

  4. Chen, Xiao

    1. Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052

  5. Chen, Xiaobing

    1. Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
      Ruining Gong, Yan Huang, Xiaoxuan Wang, Xiaobing Chen, Zibin Tian and He Ren
      Cancer Biology & Medicine November 2021, 18 (4) 937-939; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0406

  6. Chen, Xin

    1. Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas
      Ping Li, Fengyang Chen, Jingbin Zheng, Yang Yang, Yuan Li, Yifei Wang and Xin Chen
      Cancer Biology & Medicine November 2021, 18 (4) 1010-1020; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0027

  7. Chen, Yu

    1. Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022

  8. Cui, Jiuwei

    1. Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052

D

  1. Du, Weijiao

    1. Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037

F

  1. Fan, Jia

    1. Single-cell RNA sequencing reveals spatial heterogeneity and immune evasion of circulating tumor cells
      Yunfan Sun, Jian Zhou, Jia Fan and Xinrong Yang
      Cancer Biology & Medicine November 2021, 18 (4) 934-936; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0466

G

  1. Gao, Quanli

    1. Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040

  2. Gong, Ruining

    1. Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
      Ruining Gong, Yan Huang, Xiaoxuan Wang, Xiaobing Chen, Zibin Tian and He Ren
      Cancer Biology & Medicine November 2021, 18 (4) 937-939; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0406

  3. Gong, Zhe

    1. Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types
      Zhe Gong, Yue Yang, Jieyun Zhang and Weijian Guo
      Cancer Biology & Medicine November 2021, 18 (4) 1080-1091; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0351

  4. Guo, Weijian

    1. Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types
      Zhe Gong, Yue Yang, Jieyun Zhang and Weijian Guo
      Cancer Biology & Medicine November 2021, 18 (4) 1080-1091; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0351

  5. Guo, Zengqing

    1. Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022

H

  1. Han, Fujun

    1. Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052

  2. Han, Lu

    1. Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040

  3. Han, Ying

    1. Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037

  4. Hao, Xuezhi

    1. The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
      Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang
      Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450

  5. Hong, Jingwen

    1. Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022

  6. Hu, Jiajian

    1. EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791

  7. Hu, Xingsheng

    1. The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
      Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang
      Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450

  8. Huang, Xiaojun

    1. Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
      Zhengli Xu and Xiaojun Huang
      Cancer Biology & Medicine November 2021, 18 (4) 966-980; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0801

  9. Huang, Yan

    1. Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
      Ruining Gong, Yan Huang, Xiaoxuan Wang, Xiaobing Chen, Zibin Tian and He Ren
      Cancer Biology & Medicine November 2021, 18 (4) 937-939; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0406

  10. Huang, Yuhui

    1. The role of DLL1 in long-term vascular normalization and cancer immunotherapy
      Qiaozhen Wu and Yuhui Huang
      Cancer Biology & Medicine November 2021, 18 (4) 940-943; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0507

J

  1. Jiao, Yuchen

    1. The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
      Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang
      Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450

  2. Jin, Yanxia

    1. Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
      Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun
      Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278

K

  1. Kiyotani, Kazuma

    1. Personalized immunotherapy in cancer precision medicine
      Kazuma Kiyotani, Yujiro Toyoshima and Yusuke Nakamura
      Cancer Biology & Medicine November 2021, 18 (4) 955-965; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0032

L

  1. Li, Bo

    1. Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022

  2. Li, Hao

    1. Targeting myeloid-derived suppressor cells for cancer therapy
      Hongchao Tang, Hao Li and Zhijun Sun
      Cancer Biology & Medicine November 2021, 18 (4) 992-1009; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0806

  3. Li, Jieyu

    1. Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022

  4. Li, Lingyu

    1. Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052

  5. Li, Linlin

    1. Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040

  6. Li, Long

    1. EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791

  7. Li, Ping

    1. Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas
      Ping Li, Fengyang Chen, Jingbin Zheng, Yang Yang, Yuan Li, Yifei Wang and Xin Chen
      Cancer Biology & Medicine November 2021, 18 (4) 1010-1020; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0027

  8. Li, Runmei

    1. Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037

  9. Li, Wei

    1. Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052

  10. Li, Yan

    1. Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
      Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun
      Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278

  11. Li, Yuan

    1. Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas
      Ping Li, Fengyang Chen, Jingbin Zheng, Yang Yang, Yuan Li, Yifei Wang and Xin Chen
      Cancer Biology & Medicine November 2021, 18 (4) 1010-1020; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0027

  12. Li, Yufu

    1. Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040

  13. Liang, Tingbo

    1. Multiplex imaging reveals the architecture of the tumor immune microenvironment
      Junlei Zhang, Jinyuan Song, Jianpeng Sheng, Xueli Bai and Tingbo Liang
      Cancer Biology & Medicine November 2021, 18 (4) 949-954; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0494

  14. Lin, Wansong

    1. Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022

  15. Liu, Liang

    1. Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037

  16. Liu, Min

    1. The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023

  17. Lyu, Zheng

    1. Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052

M

  1. Meng, Yuan

    1. Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037

  2. Mi, Yuling

    1. The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
      Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang
      Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450

N

  1. Nakamura, Yusuke

    1. Personalized immunotherapy in cancer precision medicine
      Kazuma Kiyotani, Yujiro Toyoshima and Yusuke Nakamura
      Cancer Biology & Medicine November 2021, 18 (4) 955-965; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0032

P

  1. Peng, Gongxin

    1. The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
      Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang
      Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450

R

  1. Ren, He

    1. Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
      Ruining Gong, Yan Huang, Xiaoxuan Wang, Xiaobing Chen, Zibin Tian and He Ren
      Cancer Biology & Medicine November 2021, 18 (4) 937-939; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0406

  2. Ren, Xiubao

    1. Cancer immunology and immunotherapy
      Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 931-933; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0036
    2. Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies
      Hua Zhao, Hao Wang, Qiuru Zhou and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 981-991; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0029
    3. EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
    4. Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037
    5. The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023

S

  1. Shen, Meng

    1. Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037

  2. Sheng, Jianpeng

    1. Multiplex imaging reveals the architecture of the tumor immune microenvironment
      Junlei Zhang, Jinyuan Song, Jianpeng Sheng, Xueli Bai and Tingbo Liang
      Cancer Biology & Medicine November 2021, 18 (4) 949-954; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0494

  3. Song, Jiaqi

    1. Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
      Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun
      Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278

  4. Song, Jinyuan

    1. Multiplex imaging reveals the architecture of the tumor immune microenvironment
      Junlei Zhang, Jinyuan Song, Jianpeng Sheng, Xueli Bai and Tingbo Liang
      Cancer Biology & Medicine November 2021, 18 (4) 949-954; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0494

  5. Song, Wei

    1. Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052

  6. Song, Yongping

    1. Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040

  7. Su, Yanting

    1. Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
      Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun
      Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278

  8. Su, Yudong

    1. EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791

  9. Sun, Hui

    1. Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
      Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun
      Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278

  10. Sun, Qian

    1. EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
    2. The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023

  11. Sun, Yunfan

    1. Single-cell RNA sequencing reveals spatial heterogeneity and immune evasion of circulating tumor cells
      Yunfan Sun, Jian Zhou, Jia Fan and Xinrong Yang
      Cancer Biology & Medicine November 2021, 18 (4) 934-936; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0466

  12. Sun, Zhijun

    1. Targeting myeloid-derived suppressor cells for cancer therapy
      Hongchao Tang, Hao Li and Zhijun Sun
      Cancer Biology & Medicine November 2021, 18 (4) 992-1009; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0806

T

  1. Tang, Hongchao

    1. Targeting myeloid-derived suppressor cells for cancer therapy
      Hongchao Tang, Hao Li and Zhijun Sun
      Cancer Biology & Medicine November 2021, 18 (4) 992-1009; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0806

  2. Tian, Zibin

    1. Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
      Ruining Gong, Yan Huang, Xiaoxuan Wang, Xiaobing Chen, Zibin Tian and He Ren
      Cancer Biology & Medicine November 2021, 18 (4) 937-939; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0406

  3. Toyoshima, Yujiro

    1. Personalized immunotherapy in cancer precision medicine
      Kazuma Kiyotani, Yujiro Toyoshima and Yusuke Nakamura
      Cancer Biology & Medicine November 2021, 18 (4) 955-965; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0032

W

  1. Wang, Hao

    1. Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies
      Hua Zhao, Hao Wang, Qiuru Zhou and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 981-991; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0029

  2. Wang, Jian

    1. The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023

  3. Wang, Xiaobing

    1. The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
      Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang
      Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450

  4. Wang, Xiaoxuan

    1. Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
      Ruining Gong, Yan Huang, Xiaoxuan Wang, Xiaobing Chen, Zibin Tian and He Ren
      Cancer Biology & Medicine November 2021, 18 (4) 937-939; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0406

  5. Wang, Xueqing

    1. Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
      Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun
      Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278

  6. Wang, Yan

    1. The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
      Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang
      Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450

  7. Wang, Yang

    1. EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
    2. Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037

  8. Wang, Yifei

    1. Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas
      Ping Li, Fengyang Chen, Jingbin Zheng, Yang Yang, Yuan Li, Yifei Wang and Xin Chen
      Cancer Biology & Medicine November 2021, 18 (4) 1010-1020; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0027

  9. Wei, Feng

    1. EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
    2. The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023

  10. Wu, Qiaozhen

    1. The role of DLL1 in long-term vascular normalization and cancer immunotherapy
      Qiaozhen Wu and Yuhui Huang
      Cancer Biology & Medicine November 2021, 18 (4) 940-943; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0507

X

  1. Xiao, Jun

    1. EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791

  2. Xiong, Yanjuan

    1. Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037

  3. Xu, Bo

    1. Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
      Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun
      Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278

  4. Xu, Zhengli

    1. Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
      Zhengli Xu and Xiaojun Huang
      Cancer Biology & Medicine November 2021, 18 (4) 966-980; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0801

Y

  1. Yang, Fan

    1. The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023

  2. Yang, Ke

    1. The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
      Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang
      Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450

  3. Yang, Lili

    1. The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023

  4. Yang, Lin

    1. Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037

  5. Yang, Lu

    1. The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
      Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang
      Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450

  6. Yang, Qing

    1. Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
      Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun
      Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278

  7. Yang, Xinrong

    1. Single-cell RNA sequencing reveals spatial heterogeneity and immune evasion of circulating tumor cells
      Yunfan Sun, Jian Zhou, Jia Fan and Xinrong Yang
      Cancer Biology & Medicine November 2021, 18 (4) 934-936; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0466

  8. Yang, Yang

    1. Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas
      Ping Li, Fengyang Chen, Jingbin Zheng, Yang Yang, Yuan Li, Yifei Wang and Xin Chen
      Cancer Biology & Medicine November 2021, 18 (4) 1010-1020; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0027

  9. Yang, Yue

    1. Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types
      Zhe Gong, Yue Yang, Jieyun Zhang and Weijian Guo
      Cancer Biology & Medicine November 2021, 18 (4) 1080-1091; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0351

  10. Ye, Chunmei

    1. Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022

  11. Ye, Xiangdong

    1. Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
      Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun
      Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278

  12. Ye, Yunbin

    1. Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022

  13. Yin, Huihui

    1. The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
      Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang
      Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450

  14. Yin, Jie

    1. EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791

  15. Yin, Qingsong

    1. Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040

  16. You, Hongqin

    1. Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040

  17. Yu, Huahui

    1. Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022

  18. Yu, Jinpu

    1. The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023

  19. Yu, Wenhui

    1. Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
      Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun
      Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278

  20. Yu, Wenwen

    1. EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
    2. The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023

  21. Yu, Yingyan

    1. Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers
      Yingyan Yu
      Cancer Biology & Medicine November 2021, 18 (4) 944-948; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0491

  22. Yuan, Yuan

    1. Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022

Z

  1. Zeng, Ziqing

    1. The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023

  2. Zhang, Chen

    1. EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791

  3. Zhang, Hong

    1. EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791

  4. Zhang, Jieyun

    1. Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types
      Zhe Gong, Yue Yang, Jieyun Zhang and Weijian Guo
      Cancer Biology & Medicine November 2021, 18 (4) 1080-1091; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0351

  5. Zhang, Jishuai

    1. Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040

  6. Zhang, Junlei

    1. Multiplex imaging reveals the architecture of the tumor immune microenvironment
      Junlei Zhang, Jinyuan Song, Jianpeng Sheng, Xueli Bai and Tingbo Liang
      Cancer Biology & Medicine November 2021, 18 (4) 949-954; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0494

  7. Zhang, Peng

    1. The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023

  8. Zhang, Weihong

    1. Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037

  9. Zhang, Xinwei

    1. Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037
    2. The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023

  10. Zhang, Xuzhen

    1. EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791

  11. Zhang, Yingchi

    1. EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791

  12. Zhang, Yongfei

    1. Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052

  13. Zhao, Hua

    1. Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies
      Hua Zhao, Hao Wang, Qiuru Zhou and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 981-991; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0029

  14. Zhao, Lingdi

    1. Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040

  15. Zhao, Qiang

    1. EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791

  16. Zhao, Yuguang

    1. Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052

  17. Zheng, Jian

    1. EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791

  18. Zheng, Jingbin

    1. Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas
      Ping Li, Fengyang Chen, Jingbin Zheng, Yang Yang, Yuan Li, Yifei Wang and Xin Chen
      Cancer Biology & Medicine November 2021, 18 (4) 1010-1020; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0027

  19. Zhou, Jian

    1. Single-cell RNA sequencing reveals spatial heterogeneity and immune evasion of circulating tumor cells
      Yunfan Sun, Jian Zhou, Jia Fan and Xinrong Yang
      Cancer Biology & Medicine November 2021, 18 (4) 934-936; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0466
    2. Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040

  20. Zhou, Kaichen

    1. EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791

  21. Zhou, Keshu

    1. Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040

  22. Zhou, Li

    1. Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037

  23. Zhou, Qiuru

    1. Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies
      Hua Zhao, Hao Wang, Qiuru Zhou and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 981-991; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0029

  24. Zhu, Xinghu

    1. Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040
Back to top

In this issue

Cancer Biology & Medicine: 18 (4)
Cancer Biology & Medicine
Vol. 18, Issue 4
1 Nov 2021

Submit

Sign up for alerts